This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Official event dates: January 11–15, 2021
Post-show access until March 31, 2021

Kimberly Ha
CEO and Founder at KKH Advisors


Kimberly is Founder and CEO of KKH Advisors, a life sciences and digital health strategic communications firm. She was previously Senior Director at FTI Consulting, Life Sciences and Healthcare, where she advised a broad range of clients from Fortune 500 to early-stage companies on business transformation, corporate and executive positioning, crisis and issues management, and financial communications. Prior to FTI Consulting (NYSE:FCN), she was Global Editor at BioPharm Insight, a business intelligence service launched by the Financial Times Group. She started her career as an M&A reporter in Hong Kong covering pharmaceuticals and healthcare, before transferring to the New York bureau in 2007. Kimberly is a frequent guest speaker at major industry conferences, including BIO International, Prix Galien Forum, Biotech Showcase, FierceBiotech, MedCity Invest, Davis Polk IPO Seminars, and others. She has been a guest lecturer at Columbia University Graduate School of Computer Science and a speaker at Weill Cornell Medicine Bioventure eLab. In 2011, based on her extensive coverage of Alzheimer's disease, she was nominated by the Alzheimer's Association as a National Press Foundation Fellow. She is also recipient of the National Press Foundation and United Nations Foundation Global Vaccines Press Fellowship 2012, the Association of Health Care Journalists 2012 Fellowship Award (New York State Health Foundation), and the National Press Foundation 2012 Fellowship on Cancer Issues in Washington, D.C. Kimberly is a Board Member for the Galien Foundation, and an advisor to two Stanford Medical digital health startups, Savonix and Univfy. She is a digital health advisor at UCSF Health Hub, Springboard Enterprises, and a Limited Partner at Array Ventures, a SF-based tech VC fund. She is on the editorial board for the World Korean Medical Journal, and was a mentor at Health 2.0's TECHquality program, which fosters diversity in digital health. She has a B.A in Psychology from New York University. She is fluent in Cantonese, Shanghainese, and Mandarin.

Agenda Sessions

  • In conversation with the COVID-19 leaders: The Novavax COVID-19 Journey

    On Demand
  • Media round-up live: Heard virtually around the social media square


Speakers at this event